Curaleaf Opens New Medical Cannabis Dispensary in Nassau County New York

Carle Place becomes the medical cannabis leader’s fourth location in the state

CARLE PLACE, N.Y., Jan. 4, 2019 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) / OTCPK: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator, today opened its fourth dispensary in New York State. Located at 255 Glen Cove Road in Carle Place, Long Island, the new location will provide medical cannabis patients in Nassau and Suffolk counties easier and more convenient access to necessary medicine. This new location will be the company’s 36^th dispensary.

As a service to patients and the community, Curaleaf’s Carle Place location will also manage a range of free wellness and medical marijuana educational programs such as health seminars led by medical professionals and yoga classes. As with its other dispensaries throughout the state, the company plans to support local community events and initiatives such as the Susan G. Komen annual “Race For The Cure,” EPIC Long Island, and the Multiple Sclerosis Society of NY and Long Island.

“Our patients are always our top priority and we are continuously working to identify new ways for them to access the medication they need,” said Michelle Bodner, President of Curaleaf New York. “This new location will serve a community of patients in Long Island and provide them with high-quality medical cannabis used to help patients suffering from chronic pain, cancer, opioid addiction, PTSD and other ailments.”

“I am thrilled to know that there is a new medical cannabis dispensary opening in the central Nassau county region. With 60 miles between the two existing Long Island dispensaries and limitations in delivery services, there is a real need for greater accessibility to medical cannabis for Long Island patients,” said Diana Martins-Welch, MD, Hospice and Palliative Medicine Specialist at Northwell Health. “I’m confident that Curaleaf will not only be able to meet this need but will offer high quality services and products to our patients. I look forward to working with Curaleaf’s new dispensary.”

The opening comes on the heels of Curaleaf New York’s expanded and affordable new product line. Three new products and nine new SKU’s – Curaleaf Slim Vape Pen, Peppermint Flavored Tincture, and Lemon Flavored Tinctures – are made with Curaleaf cannabis grown in the state and processed at the company’s cultivation facility in Ravena, NY. Some of the high-quality cannabis products are available starting at just $25, making them approximately 60 percent less than similar products in the state. Mint Flavored Micro Tablets in three cannabinoid concentrations will be available later this month.

The dispensary’s operating hours are Tuesday through Thursday and Saturday, 10:30am – 6pm; Friday, 11:30am -7pm; closed on Sundays and Mondays. Throughout the year, discounts are offered to military veterans and recipients of Medicaid.

Curaleaf New York also operates medical cannabis dispensaries in Newburgh, Plattsburgh and Forest Hills, Queens. Images of Curaleaf dispensaries can be found here.

About Curaleaf Holdings, Inc.

The Company is the parent of Curaleaf, Inc., a leading vertically integrated cannabis operator in the United States. Headquartered in Wakefield, Massachusetts, Curaleaf, Inc. has a presence in 12 states. Curaleaf, Inc. operates 36 dispensaries, 12 cultivation sites and 10 processing sites with a focus on highly populated, limited license states, including Florida, Massachusetts, New Jersey and New York. Curaleaf, Inc. leverages its extensive research and development capabilities to distribute cannabis products in multiple formats with the highest standard for safety, effectiveness, consistent quality and customer care. Curaleaf is committed to being the industry’s leading resource in education and advancement through research and advocacy. Curaleaf, Inc.’s Florida operations were the first in the cannabis industry to receive the Safe Quality Food certification under the Global Food Safety Initiative, setting a new standard of excellence.

CONTACT:
Samantha Qualls
Curaleaf@marinopr.com
212.889.0808

Company Contact:
Curaleaf Holdings, Inc.
Christine Rigby, SVP, Investor Relations
PH: (781) 451-0145
Info@curaleaf.com

SOURCE Curaleaf Holdings, Inc.